Viewing Study NCT01284569


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-30 @ 5:05 PM
Study NCT ID: NCT01284569
Status: COMPLETED
Last Update Posted: 2019-01-04
First Post: 2011-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients
Sponsor: Ablynx, a Sanofi company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module